Sivia Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$878K Sell
3,459
-5,184
-60% -$1.21M 0.11% 230
2026
Q1
$2.11M Buy
8,643
+26
+0.3% +$6.06K 0.41% 45
2025
Q4
$1.78M Buy
8,617
+698
+9% +$138K 0.36% 43
2025
Q3
$1.47M Buy
7,919
+2,056
+35% +$352K 0.41% 30
2025
Q2
$896K Buy
5,863
+692
+13% +$106K 0.3% 51
2025
Q1
$858K Buy
5,171
+1,663
+47% +$260K 0.4% 33
2024
Q4
$507K Sell
3,508
-1,084
-24% -$168K 0.25% 53
2024
Q3
$744K Buy
4,592
+935
+26% +$149K 0.44% 36
2024
Q2
$534K Sell
3,657
-949
-21% -$141K 0.36% 47
2024
Q1
$729K Buy
4,606
+830
+22% +$132K 0.5% 32
2023
Q4
$592K Buy
+3,776
New +$579K 0.45% 36

Other funds holding JNJ

Sivia Capital Partners's JNJ Position: Q2 2026 in Review

Sivia Capital Partners reduced its Johnson & Johnson (JNJ) stake by 60% in Q2 2026, selling an estimated $1.21M and leaving 3,459 shares worth $878K. The position accounts for 0.11% of the portfolio, ranked #230.

Sivia Capital Partners first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.11M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sivia Capital Partners held 3,459 shares of Johnson & Johnson worth $878K as of Q2 2026.
  • Sivia Capital Partners sold 5,184 Johnson & Johnson shares in Q2 2026, an estimated $1.21M.
  • Johnson & Johnson made up 0.11% of Sivia Capital Partners's portfolio in Q2 2026, its #230 holding.
  • Sivia Capital Partners first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Sivia Capital Partners's Johnson & Johnson position peaked at $2.11M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.